(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 4.99% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.08%.
Azenta's revenue in 2025 is $604,933,000.On average, 10 Wall Street analysts forecast AZTA's revenue for 2026 to be $28,781,390,019, with the lowest AZTA revenue forecast at $26,930,840,200, and the highest AZTA revenue forecast at $30,178,584,929.  On average, 9 Wall Street analysts forecast AZTA's revenue for 2027 to be $30,060,318,431, with the lowest AZTA revenue forecast at $27,383,736,713, and the highest AZTA revenue forecast at $31,784,808,998.  
In 2028, AZTA is forecast to generate $32,545,748,483 in revenue, with the lowest revenue forecast at $31,269,112,058 and the highest revenue forecast at $33,502,882,003.